Clinical Trial Update: Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase pharmacokinetic analysis results for Antitumor B in patients with oral cancer, based on a completed Phase 1 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Oral Cavity

Drugs mentioned

• Antitumor B

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Squamous Cell Carcinoma of the Oral Cavity | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2023-04-21